Categories

Volume 9 Issue 6 (June, 2021)

Original Articles

A comparative study of analgesic effect of ESPB with TPVB in breast surgery
Dr. Kumar Nishant Singh, Dr Nitu Singh

Background: Breast cancer is the most commonly diagnosed cancer and the second most common cause of cancer death in women. The present study was conducted to compare the analgesic effect of ESPB with TPVB in breast surgery. Materials & Methods: 60 adult female patients scheduled for unilateral modified radical mastectomy were divided into 2 groups of 30 each. Group I were those who received TPVB and group II received ESPB. Parameters such as post operative 24 hours morphine consumption, intra-operative fentanyl consumption, time of the first request for analgesia and complications were recorded. Results: The mean BMI in group I patients was 27.2 Kg/m2 and in group II was 28.5 Kg/m2. ASA grade I was seen in 22 in group I and 21 in group II and II in 8 in group I and 9 in group II. Duration of surgery was 174.2 minutes in group I and 170.2 minutes in group II. The intra‑operative fentanyl consumption (µg) was 139.3 in group I and 134.2 in group II, total post‑operative morphine (mg) was 27.2 in group I and 26.5 in group II. Time to first analgesic request was 6.32 hours in group I and 6.51 hours in group II. Nausea was seen in 10 in group I and 9 in group II, vomiting 4 in group I and 3 in group II and pneumothorax 3 in group I and 1 in group II. The difference was non- significant (P> 0.05). Conclusion: Both TPVB and ESPB provide effective pain control after breast surgeries.

 
Html View | Download PDF | Current Issue